Promising New Therapies for Malignant Gliomas
- 1 November 2007
- journal article
- review article
- Published by Wolters Kluwer Health in The Cancer Journal
- Vol. 13 (6) , 349-354
Abstract
Since the publication of the 7th edition of Cancer, Principles & Practice of Oncology, there have been several potentially important advances in the treatment of patients with high-grade gliomas. These advances have occurred in the area of molecular targeting of the epidermal growth factor receptor and in attempts to inhibit glioma-associated angiogenesis. For the first time ever, drugs are being used that can cause reproducible and clinically meaningful tumor responses in patients with recurrent malignant gliomas. Unfortunately, the number of patients with long-term responses to these agents remains relatively low. Identification of biomarkers that will allow a more accurate prediction of which patients are likely to benefit from a specific treatment and new radiographic criteria of true drug-mediated antitumor effects will be increasingly important as new molecular targeted agents are evaluated in patients with primary brain tumors.Keywords
This publication has 27 references indexed in Scilit:
- AKT/PKB Signaling: Navigating DownstreamCell, 2007
- Epidermal growth factor receptor mutations in lung cancerNature Reviews Cancer, 2007
- AZD2171, a Pan-VEGF Receptor Tyrosine Kinase Inhibitor, Normalizes Tumor Vasculature and Alleviates Edema in Glioblastoma PatientsCancer Cell, 2007
- EGF–ERBB signalling: towards the systems levelNature Reviews Molecular Cell Biology, 2006
- Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesisNature Reviews Cancer, 2006
- Erlotinib in Previously Treated Non–Small-Cell Lung CancerNew England Journal of Medicine, 2005
- Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to GefitinibNew England Journal of Medicine, 2004
- Epidermal Growth Factor Receptor-dependent, NF-κB-independent Activation of the Phosphatidylinositol 3-Kinase/Akt Pathway Inhibits Ultraviolet Irradiation-induced Caspases-3, -8, and -9 in Human KeratinocytesJournal of Biological Chemistry, 2003
- PTEN , a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate CancerScience, 1997
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971